GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 1 filers reported holding GALERA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $85,851 | -3.7% | 613,223 | 0.0% | 0.08% | +42.9% |
| Q4 2023 | $89,163 | -17.0% | 613,223 | 0.0% | 0.06% | -35.6% |
| Q3 2023 | $107,375 | -94.4% | 613,223 | 0.0% | 0.09% | -92.9% |
| Q2 2023 | $1,913,256 | +21.9% | 613,223 | 0.0% | 1.22% | +14.5% |
| Q1 2023 | $1,569,851 | +71.8% | 613,223 | 0.0% | 1.07% | +69.5% |
| Q4 2022 | $913,702 | -14.4% | 613,223 | 0.0% | 0.63% | -7.5% |
| Q3 2022 | $1,067,000 | +33.9% | 613,223 | 0.0% | 0.68% | +24.5% |
| Q2 2022 | $797,000 | -45.4% | 613,223 | 0.0% | 0.55% | -21.0% |
| Q1 2022 | $1,459,000 | -48.2% | 613,223 | 0.0% | 0.69% | -16.9% |
| Q4 2021 | $2,815,000 | -43.3% | 613,223 | 0.0% | 0.83% | -47.6% |
| Q3 2021 | $4,967,000 | -17.6% | 613,223 | 0.0% | 1.59% | -15.1% |
| Q2 2021 | $6,028,000 | – | 613,223 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,083,712 | $29,295,000 | 2.71% |
| NEA Management Company, LLC | 4,362,986 | $41,448,000 | 2.17% |
| Novo Holdings A/S | 3,409,021 | $32,386,000 | 2.16% |
| SPHERA FUNDS MANAGEMENT LTD. | 475,677 | $4,519,000 | 0.56% |
| RA Capital Management | 893,115 | $8,485,000 | 0.27% |
| Rock Springs Capital Management LP | 500,000 | $4,750,000 | 0.20% |
| Tekla Capital Management LLC | 416,666 | $3,958,000 | 0.18% |
| Blackstone Inc. | 1,678,984 | $15,950,000 | 0.12% |
| Perceptive Advisors | 325,000 | $3,088,000 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,309,500 | $12,440,000 | 0.04% |